YAMO PHARMACEUTICALS
Yamo Pharmaceuticals is a clinical-stage pharmaceutical company that develops L1-79, a novel therapy for Autism spectrum disorder.
YAMO PHARMACEUTICALS
Social Links:
Industry:
Biotechnology Pharmaceutical
Founded:
2015-01-01
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.yamopharma.com
Total Employee:
1+
Status:
Active
Contact:
1-646-723-2287
Total Funding:
0
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon WordPress Wordpress Plugins Nginx
Current Advisors List
Current Employees Featured
Investors List
Autism Impact Fund
Autism Impact Fund investment in Venture Round - Yamo Pharmaceuticals
Official Site Inspections
http://www.yamopharma.com Semrush global rank: 5.84 M Semrush visits lastest month: 1.42 K
- Host name: 192.64.119.168
- IP address: 192.64.119.168
- Location: Los Angeles United States
- Latitude: 34.0318
- Longitude: -118.4252
- Metro Code: 803
- Timezone: America/Los_Angeles
- Postal: 90064
More informations about "Yamo Pharmaceuticals"
Our Team - Yamo Pharma
Launched 28 products in 15 therapeutic areas ; CEO of Pearl Therapeutics from 2011-2016 which was sold in 2013 to Astra Zeneca for $1.1B.; Previously COO of Pharmaceutical Products at …See details»
Company Overview - Yamo Pharma
Yamo Pharmaceuticals is a clinical-stage company dedicated to developing L1-79, an oral treatment targeting core social-interaction deficits in individuals with Autism Spectrum Disorder …See details»
Yamo Pharmaceuticals - Crunchbase Company Profile …
Yamo Pharmaceuticals is a clinical-stage pharmaceutical company that develops L1-79, a novel therapy for Autism spectrum disorder.See details»
Yamo Pharmaceuticals - LinkedIn
750 Lexington Ave 9th Floor - Suite 07-103 New York, NY 10022, USSee details»
Yamo Pharmaceuticals CEO and Key Executive Team | Craft.co
Yamo Pharmaceuticals's Chief Executive Officer is Chuck Bramlage. Other executives include Tom Megerian, Chief Medical Officer & Senior Vice President of Clinical Development; John …See details»
Yamo Pharmaceuticals LLC - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Yamo Pharmaceuticals LLC of New York, NY. Get the latest business insights from Dun & Bradstreet.See details»
Yamo Pharmaceuticals - Craft
Yamo Pharmaceuticals is a company developing L1-79, a therapy that targets the core symptoms of autism. The mechanism of action for L1-79 addresses both the central nervous system and …See details»
Yamo Pharmaceuticals Overview | SignalHire Company Profile
Organization Website: yamopharma.com : Phone Number: 212 610-1578: Yamo Pharmaceuticals industries Biotech: Headquarters Location: 400 Madison Avenue, New York, NY, 10017 US …See details»
General Inquiries - Yamo Pharma
About Us. Company Overview; Our Team; Scientific Advisory Board; Our Technology. Yamo’s Treatment for Autism; About Autism; Information for Patients and CaregiversSee details»
Yamo Pharmaceuticals LLC - Drug pipelines, Patents, …
Contact DataInvestor and Media ContactsChuck Bramlage, [email protected] Eugene Prahin, [email protected](212) 610-1570 i Maenner MJ, Warren Z, …See details»
Yamo Pharma Presents Statistically Significant Phase 2
4 days ago Eugene Prahin, CAO – [email protected]; Phone: (212) 610-1570; Tags Autism Autism Spectrum Disorder INSAR 2025 Yamo Pharmaceuticals L1-79 Clinical Trials …See details»
Yamo Pharmaceuticals Receives Investment from Autism Impact
New York, Nov. 10, 2021 (GLOBE NEWSWIRE) -- Yamo Pharmaceuticals LLC, a clinical stage pharmaceutical company developing a novel therapy for the core symptoms of the autism …See details»
Yamo Pharmaceuticals - Products, Competitors, Financials, …
About Yamo Pharmaceuticals Yamo Pharmaceuticals is a clinical stage pharmaceutical company founded in 2015 to develop L1-79, a novel therapy with the potential to improve the core …See details»
Yamo Pharmaceuticals - Company Profile - Tracxn
Mar 1, 2025 Yamo Pharmaceuticals - Developer of therapies to treat autism. Raised funding over 1 round from 1 investor. Yamo Pharmaceuticals has 109 competitors.See details»
Yamo Pharmaceuticals | VentureRadar
Website: http://www.yamopharma.com/ Develops a clinical-stage oral medication intended to address core symptoms of autism, including communication and socialization ...See details»
Yamo Pharmaceuticals - Overview, News & Similar companies
May 14, 2019 Yamo Pharmaceuticals contact info: Phone number: (212) 610-1578 Website: www.yamopharma.com What does Yamo Pharmaceuticals do? Yamo Pharmaceuticals is a …See details»
Yamo Pharmaceuticals Company Profile -Sales, Contacts, …
Yamo Pharmaceuticals is in the Pharmaceutical Preparations industry within the Chemicals and Allied Products sector and has been in business for approximately 10 years.See details»
Yamo Pharmaceuticals Receives Investment from Autism Impact …
New York, Nov. 10, 2021 (GLOBE NEWSWIRE) -- Yamo Pharmaceuticals, LLC, a clinical stage pharmaceutical company developing a novel therapy for the core symptoms of the autism …See details»
Yamo Pharmaceuticals Receives Investment from Autism Impact
Nov 10, 2021 Contact Data Investor and Media Contacts Chuck Bramlage, CEO [email protected] Eugene Prahin, CFO [email protected] 212-610-1570See details»
Yamo Pharma Presents Statistically Significant Phase 2 Autism …
5 days ago News & Events · May 8, 2025. Yamo Pharma Presents Statistically Significant Phase 2 Autism Results for L1-79 at INSAR 2025See details»